Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Cytokine ; 138: 155404, 2021 02.
Article in English | MEDLINE | ID: covidwho-996816

ABSTRACT

The new coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can trigger a hyperinflammatory state characterized by elevated cytokine levels known as hypercytokinemia or cytokine storm, observed most often in severe patients. Though COVID-19 is known to be a primarily respiratory disease, neurological complications affecting both the central and peripheral nervous systems have also been reported. This review discusses potential routes of SARS-CoV-2 neuroinvasion and pathogenesis, summarizes reported neurological sequelae of COVID-19, and examines how aberrant cytokine levels may precipitate these complications. Clarification of the pathogenic mechanisms of SARS-CoV-2 is needed to encourage prompt diagnosis and optimized care. In particular, identifying the presence of cytokine storm in patients with neurological COVID-19 manifestations will facilitate avenues for treatment. Future investigations into aberrant cytokine levels in COVID-19 patients with neurological symptoms as well as the efficacy of cytokine storm-targeting treatments will be critical in elucidating the pathogenic mechanisms and effective treatments of COVID-19.


Subject(s)
COVID-19/pathology , Cerebrovascular Disorders/pathology , Cytokine Release Syndrome/pathology , Cytokines/blood , Nervous System Diseases/pathology , COVID-19/therapy , Central Nervous System/pathology , Cerebrovascular Disorders/virology , Cytokine Release Syndrome/therapy , Humans , Nervous System Diseases/virology , Peripheral Nervous System/pathology , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL